Boosting the arsenal against COVID-19 through computational drug repurposing

Drug Discov Today. 2020 Jun;25(6):946-948. doi: 10.1016/j.drudis.2020.04.005. Epub 2020 Apr 15.

Authors

Gennaro Ciliberto¹, Luca Cardone²

Affiliations

¹ Scientific Directorate, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy.
² Tumor Immunology and Immunotherapy Unit, Department of Research, Advanced Diagnostics, and Technological Innovations, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy. Electronic address: luca.cardone@ifo.gov.it.

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Betacoronavirus / drug effects*
COVID-19
COVID-19 Drug Treatment
Coronavirus Infections / drug therapy*
Coronavirus Infections / virology
Drug Repositioning*
Humans
Pandemics
Pneumonia, Viral / drug therapy*
Pneumonia, Viral / virology
SARS-CoV-2